FDA (Image: AP)
As resistance to standard antibiotics grows, RedHill's H. pylori regimen secures FDA approval
In 2017, the WHO designated clarithromycin-resistant H. pylori, a bacterial infection that affects more than half of the global population, a high priority for antibiotic …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
